Maneesha Ghiya of FemHealth Ventures talks with CNBC’s Women & Wealth to discuss the optimistic future of FemTech. Ghiya shares how nearly dying from complications after childbirth prompted her to create FemHealth Ventures to be a vehicle for funding better diagnostics, research, and treatments for women’s health. Ghiya wraps up the segment by explaining how the average investor can participate in funding FemTech, what investors look for in a company, and by expressing her excitement about the Sonata Treatment, a groundbreaking incisionless treatment option for symptomatic uterine fibroids.
Watch the video on CNBC.com.